Evidence map›Paper›PMID 34962381›Full record

ArticleAnalytical chemistry2022

Characterization of

Yuefan Wang, Yingwei Hu, Naseruddin Höti, Lan Huang, Hui Zhang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. All-in-One Pseudo-MSJournal of the American Society for Mass Spectrometry · 2023
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yuefan WangDepartment of Pathology, Johns Hopkins University, Baltimore, Maryland 21231, United States.ORCID 0000-0001-5731-6143
Yingwei HuDepartment of Pathology, Johns Hopkins University, Baltimore, Maryland 21231, United States.ORCID 0000-0002-4629-0985
Naseruddin HötiDepartment of Pathology, Johns Hopkins University, Baltimore, Maryland 21231, United States.
Lan HuangDepartment of Physiology and Biophysics, University of California, Irvine, California 92697, United States.ORCID 0000-0002-3140-4687
Hui ZhangDepartment of Pathology, Johns Hopkins University, Baltimore, Maryland 21231, United States.ORCID 0000-0001-8726-7098
Johns Hopkins University · USUniversity of California, Irvine · US

Funding

Glycoprotein biomarkers for the early detection of aggressive prostate cancerU01CA152813 · NCI · JOHNS HOPKINS UNIVERSITY · PI ZHANG, HUI · 2010 to 2021
$6.2M
Proteomics of the Proteasome Interacting NetworksR01GM074830 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI HUANG, LAN · 2005 to 2022
$6.1M
The Comprehensive Proteome Characterization Center at Johns Hopkins: High Precision Discovery and Confirmation of Genoproteomic TargetsU24CA210985 · NCI · JOHNS HOPKINS UNIVERSITY · PI CHAN, DANIEL WANYUI, ZHANG, HUI · 2016 to 2020
$5.3M
NCI NIH HHS U01 CA152813NCI NIH HHS U24 CA210985NIGMS NIH HHS R01 GM074830
6 · The paper itself

Abstract

Cells perform various functions by proteins

Indexed as

ProteinsProteomicsChromatography, GelCross-Linking ReagentsMass SpectrometryCross-Linking ReagentsProteins

Identifiers

PMID34962381
PMCPMC9006583
OpenAlexW4200236727

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.